Ultraviolet A-1 Light Therapy for Systemic Lupus Erythematosus Treatment
ultraviolet A-1 light treatment
Autoimmune Diseases+11
+ Infections
+ Joint Diseases
Treatment Study
Summary
Study start date: September 1, 1991
Actual date on which the first participant was enrolled.PROTOCOL OUTLINE: Treatment with ultraviolet A-1 light is administered 5 days a week for 6 weeks, at the lowest dose or frequency required to maintain a response. The dose and frequency are progressively decreased over the next 9 weeks.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.20 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 15 to 70 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- Patients ages 15 to 70 with symptomatic systemic lupus erythematosus meeting American Rheumatism Association criteria and normal controls --Prior/Concurrent Therapy-- No requirement for tetracycline or other photosensitizing drugs
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 2 locations
General Clinical Research Center and Charity Hospital (University of Louisiana)
New Orleans, United StatesOpen General Clinical Research Center and Charity Hospital (University of Louisiana) in Google MapsAlton Ochsner Medical Foundation Hospital
New Orleans, United States